The drug maker had earlier announced that the phase-I clinical trial of its COVID-19 vaccine candidate, ZyCoV-D, has been completed and it has commenced phase-II clinical trials from August.from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2HKTwoK
via IFTTT
0 comments:
Post a Comment